Forbes - The drugmaker has not cited any major advantages Pristiq might have over the $3.8 billion-a-year Effexor in treating depression, but has suggested it may be less likely to interact with other medicines because it is broken down differently. “This is a Read more

Windsor Star - co-authored a report with University of Connecticut professor Irving Kirsch, shaking up the mental health field last Tuesday by asserting “happy pills” swallowed by millions every day are virtually no better than placebos at treating depression. Read more

Medical News Today - The same data also showed that Seroxat was no more effective than placebo at treating depression in the under-18s. The drug had never been approved for pediatric use, but doctors are allowed to prescribe unapproved drugs “off label”. Seroxat was Read more

This entry was posted on Saturday, March 15th, 2008 at 10:30 am and is filed under Depression Treatment. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.